Jules Bordet Institute
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1939-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.bordet.be
HER2 Molecular Imaging with 89Zr-trastuzumab PET/CT As a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients with Advanced HER2-positive Breast Cancer
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-09-13
- Last Posted Date
- 2024-09-13
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 87
- Registration Number
- NCT06595563
Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy.
Not Applicable
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-26
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 284
- Registration Number
- NCT06523634
- Locations
- 🇧🇪
Jules Bordet Institute, H.U.B, Brussels, Belgium
Assessment of DW-MRI Measures : Reproducibility and Repeatability in Pelvic Imaging on MR-Linac With Healthy Volunteers
Not Applicable
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-14
- Last Posted Date
- 2024-06-14
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06458725
A Phase I Study to Assess the Tolerability of 225Ac-DOTATATE in Patients With Refractory and Relapsing Multiple Myeloma Expressing Somatostatin Receptors
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-13
- Last Posted Date
- 2024-05-13
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 30
- Registration Number
- NCT06411301
- Locations
- 🇧🇪
Jules Bordet Institute, Brussels, Belgium
Effects of Oxygen After Abdominal Oncological Surgery
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-04-10
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 49
- Registration Number
- NCT06321874
- Locations
- 🇧🇪
Khalife Maher, Brussels, Belgium
Evaluation of the RESTART Survival Programme
Not yet recruiting
- Conditions
- First Posted Date
- 2024-02-28
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 200
- Registration Number
- NCT06283511
Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal Metastases
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2024-02-01
- Last Posted Date
- 2024-02-01
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 20
- Registration Number
- NCT06237582
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study
- First Posted Date
- 2024-01-26
- Last Posted Date
- 2024-12-03
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 250
- Registration Number
- NCT06227338
- Locations
- 🇧🇪
Jules Bordet Institute, Brussels, Belgium
Ketorolac and Pregabalin Effects on breaSt Cancer (KePreSt)
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2023-11-29
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 112
- Registration Number
- NCT06150898
- Locations
- 🇧🇪
Imane Bachir, Brussels, Belgium
Molecular Imaging of FAP Expressing Cancer-associated Fibroblasts in NSCLC Treated With Immune-checkpoint Inhibitors
- First Posted Date
- 2023-10-30
- Last Posted Date
- 2023-10-30
- Lead Sponsor
- Jules Bordet Institute
- Target Recruit Count
- 58
- Registration Number
- NCT06107608
- Locations
- 🇧🇪
Institut Jules Bordet, Brussels, Belgium
© Copyright 2024. All Rights Reserved by MedPath